Search research articles
Contact Us
Filters
Showing results (571-580 of 576) with videos related to
Page
of 58
Sort By:
You have reached the last page of results.
This site can display upto 576 results.
The Journal of Clinical Investigation
|
July 2, 2019
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
Pardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
The Journal of Clinical Investigation
|
May 18, 2018
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
Pardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
Respiratory Research
|
November 21, 2009
Eosinophil and T cell markers predict functional decline in COPD patients
Jeanine M D'Armiento, Steven M Scharf, Michael D Roth, et al.
Infection Control and Hospital Epidemiology
|
December 17, 2013
Eliminating central line-associated bloodstream infections: a national patient safety imperative
Sean M Berenholtz, Lisa H Lubomski, Kristina Weeks, et al.
Lancet (London, England)
|
June 17, 2008
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial
Sarah A Frech, Herbert L Dupont, A Louis Bourgeois, et al.
Frontiers in Bacteriology
|
November 27, 2025
Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic <i>Escherichia coli</i> in healthy Bangladeshi adults delivered by three different routes
Taufiqur Rahman Bhuiyan, Farhana Khanam, Salima Raiyan Basher, et al.
Page
of 58
Search research articles
Search
Showing results (571-580 of 576) with videos related to
Sort By:
Page
of 58
You have reached the last page of results.
This site can display upto 576 results.
The Journal of Clinical Investigation
|
July 2, 2019
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
Pardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
The Journal of Clinical Investigation
|
May 18, 2018
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
Pardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
Respiratory Research
|
November 21, 2009
Eosinophil and T cell markers predict functional decline in COPD patients
Jeanine M D'Armiento, Steven M Scharf, Michael D Roth, et al.
Infection Control and Hospital Epidemiology
|
December 17, 2013
Eliminating central line-associated bloodstream infections: a national patient safety imperative
Sean M Berenholtz, Lisa H Lubomski, Kristina Weeks, et al.
Lancet (London, England)
|
June 17, 2008
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial
Sarah A Frech, Herbert L Dupont, A Louis Bourgeois, et al.
Frontiers in Bacteriology
|
November 27, 2025
Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic <i>Escherichia coli</i> in healthy Bangladeshi adults delivered by three different routes
Taufiqur Rahman Bhuiyan, Farhana Khanam, Salima Raiyan Basher, et al.
Page
of 58